Damien Conover talks about emerging markets and the channels for pharmaceutical companies to succeed there. 

Damien Conover: When we look at the pharmaceutical landscape over the last few years, we’ve seen valuations improve significantly. A lot of this is being driven by three key areas. The first of which is the end of the patent cliff, which really peaked in the 2012 time period. The second point is the growing importance of emerging markets, which are offering a new channel of demand for pharmaceutical products. The third reason has to do with increased productivity in the pipelines, which will bring forward next-generation drugs at a much faster rate than what we have seen for some time.

Read the source article at forbes.com


General Blogs Engineering & Technology Biosciences Management Sciences Education Pharmaceutical Sciences Design & Visual Arts

Best pharmacy university in Delhi NCR | Top law university in Delhi NCR | Best B.Ed university in Delhi NCR | Best MBA university in Delhi NCR | Top journalism colleges in delhi ncr | Top engineering colleges in Delhi NCR | Best university in Gurgaon, Haryana | Top university in Delhi NCR